Improdia is Monitoring the Immune Status

Improdia is an innovative, diagnostic company that is developing a simple blood test, that through monitoring the immune status of cancer patients predicts efficiency of immunotherapy when combined with cannabis, it also identifies diabetic patients at risk to develop future complications.

Proof of Concept
Biomarkers
The Test Kit
The Need
Current Situation

Miriam Lerner M.Sc.

CoCEO, CTO

Miriam Lerner M.Sc.

CoCEO, CTO

Miriam Lerner

Ms. Lerner received her MSc in applied microbiology from the Hebrew University of Jerusalem. For over 20 years she has been involved in the R&D of diagnostic technologies, previously holding senior management positions in two companies from their establishment stage. She is experienced in leading project and research teams, as well as in QA Management. Miriam has co-authored several scientific publications relating to her research.

Dr. Roy Eldor, M.D.

Medical Director

Dr. Roy Eldor, M.D.

Medical Director

Dr. Eldor is the Director of the Diabetes Unit in the institute for Endocrinology, Metabolism and Hypertension, in the Tel Aviv Sourasky Medical Center, Israel, the Director of the Central District Diabetes Clinic at the Leumit HMO, Israel, and a Principal Scientist in Clinical Research on Diabetes & Endocrinology at the Merck Research Laboratories, USA. He is an endocrinologist, internist and researcher with over twenty years of clinical, academic and scientific experience; and a recognized international expert and speaker with over 40 peer reviewed publications.

Prof. Ido Wolf

Member of the Scientific Advisory Board

Prof. Ido Wolf

Member of the Scientific Advisory Board

Prof. Wolf specializes in research on gastrointestinal malignancies, neuroendocrine tumors and the endocrine aspects of cancer. He served as the Head of the Oncology Department at the Chaim Sheba Medical Center (2008-2012) and since 2012 he has been the Head of the Oncology Division at Tel Aviv Sourasky Medical Center.

Prof. Dedi Meiri

Member of the Scientific Advisory Board

Prof. Dedi Meiri

Member of the Scientific Advisory Board

Prof. Meiri is a lecturer, researcher and faculty member at the Technion Institute of Technology, in the fields of Cancer Biology and Cannabinoid Research. He holds a master’s degree in biochemistry, a doctorate in plant biotechnology from Tel Aviv University and a post-doctorate from the Cancer Institute in Toronto. He has published five articles on pancreatic cancer, ovarian cancer, and cancerous metastasis.

Prof.  Michal Baniyash

Inventor

Prof.  Michal Baniyash

Inventor

Prof. Baniyash received her Ph.D. in Immunology from the Weizmann Institute of Science and is currently a lecturer and principle investigator in the Department of Immunology and Cancer Research at the Hebrew University of Jerusalem. She has more than 20 years of experience leading immunological research on the mechanisms and clinical implications of chronic inflammation and suppression of the immune system in various diseases; and has over 50 publications in prestigious medical journals and numerous inventions on biomarkers in her field.

Raphael Nir Ph.D.

Co-Founder

Raphael Nir Ph.D.

Co-Founder

Received his PhD in Biotechnology at  Tel-Aviv University. A scientist, entrepreneur and angel investor with over 27 years of experience commercializing recombinant cytokines and pre-clinical contract research services. He is the co-founder of two pre-clinical contract research organizations: SBH Sciences and Woodland Biosciences; and three biotechnology companies: Karyopharm Therapeutics (NASDAQ: KPTI), Galectin Sciences and Alma Bio Therapeutics.

Gil Pogozelich Ph.D.

Chairman

Gil Pogozelich Ph.D.

Chairman

Dr. Pogozelich is highly experienced, and for 20 years has been leading successful technology startups. Now specializes in the development, integration and commercialization of Life Science technologies, with emphasis on the field of personalized medicine. Previously specialized in the management of complex development teams in algorithms and engineering and has registered and co-registered a number of patents.